407 related articles for article (PubMed ID: 17252256)
21. [Paget's disease of bone: new therapeutic strategies].
D'Amore M; Lisi S; Sisto M; De Marino AV
Recenti Prog Med; 2013 Mar; 104(3):89-92. PubMed ID: 23548950
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological therapy of Paget's and other metabolic bone diseases.
Hosking D
Bone; 2006 Feb; 38(2 Suppl 2):S3-7. PubMed ID: 16406763
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of drugs for Paget's disease of bone.
Reginster JY; Lecart MP
Bone; 1995 Nov; 17(5 Suppl):485S-488S. PubMed ID: 8573423
[TBL] [Abstract][Full Text] [Related]
24. Zoledronic acid for treatment of Paget's disease of bone.
Devogelaer JP; Manicourt DH
Expert Opin Pharmacother; 2007 Nov; 8(16):2863-9. PubMed ID: 17956205
[TBL] [Abstract][Full Text] [Related]
25. Clinical practice. Paget's disease of bone.
Whyte MP
N Engl J Med; 2006 Aug; 355(6):593-600. PubMed ID: 16899779
[No Abstract] [Full Text] [Related]
26. Paget's Disease of Bone: Diagnosis and Treatment.
Kravets I
Am J Med; 2018 Nov; 131(11):1298-1303. PubMed ID: 29752905
[TBL] [Abstract][Full Text] [Related]
27. Diagnosis and treatment of Paget's disease of bone : A clinical practice guideline.
Muschitz C; Feichtinger X; Haschka J; Kocijan R
Wien Med Wochenschr; 2017 Feb; 167(1-2):18-24. PubMed ID: 27600563
[TBL] [Abstract][Full Text] [Related]
28. The use of intravenous aminobisphosphonates for the treatment of Paget's disease of bone.
Gennari L; Merlotti D; Mossetti G; Rendina D; De Paola V; Martini G; Nuti R
Mini Rev Med Chem; 2009 Aug; 9(9):1052-63. PubMed ID: 19689402
[TBL] [Abstract][Full Text] [Related]
29. [Paget's disease of bone].
Holgado Pérez S; Sallés Lizarzáburu M; Olivé Marqués A
Med Clin (Barc); 2008 Oct; 131(13):509-12. PubMed ID: 19007581
[No Abstract] [Full Text] [Related]
30. [Paget's disease of bone: diagnosis and treatment].
Winter EM; Hamdy NA; de Jongh RT; Eekhoff EM; Zillikens MC; Appelman-Dijkstra NM
Ned Tijdschr Geneeskd; 2016; 160():D254. PubMed ID: 27650015
[TBL] [Abstract][Full Text] [Related]
31. [Diagnosis and management of Paget's disease of bone].
Hashimoto J; Yoshikawa H
Nihon Rinsho; 2007 Nov; 65 Suppl 9():56-64. PubMed ID: 18161082
[No Abstract] [Full Text] [Related]
32. Paget's disease of bone.
Cundy T
Metabolism; 2018 Mar; 80():5-14. PubMed ID: 28780255
[TBL] [Abstract][Full Text] [Related]
33. Clinical practice. Paget's disease of bone.
Ralston SH
N Engl J Med; 2013 Feb; 368(7):644-50. PubMed ID: 23406029
[No Abstract] [Full Text] [Related]
34. Bisphosphonates in the treatment of malignant bone disease.
Berenson JR; Lipton A
Annu Rev Med; 1999; 50():237-48. PubMed ID: 10073275
[TBL] [Abstract][Full Text] [Related]
35. Pharmacotherapy of Paget's disease of bone.
Reid IR
Expert Opin Pharmacother; 2012 Apr; 13(5):637-46. PubMed ID: 22339140
[TBL] [Abstract][Full Text] [Related]
36. Normal bone turnover markers in a patient with active Paget's disease of bone: response to treatment with zoledronic acid.
Polyzos SA; Anastasilakis AD; Anagnostis P; Kita M; Arsos G; Moralidis E; Papatheodorou A; Terpos E
Endokrynol Pol; 2012; 63(4):312-5. PubMed ID: 22933168
[TBL] [Abstract][Full Text] [Related]
37. Zoledronic acid: a review of its use in the treatment of Paget's disease of bone.
Keating GM; Scott LJ
Drugs; 2007; 67(5):793-804. PubMed ID: 17385948
[TBL] [Abstract][Full Text] [Related]
38. [Therapeutic effects of risedronate on Paget's disease of bone].
Takata S
Clin Calcium; 2006 Sep; 16(9):1508-12. PubMed ID: 16951476
[TBL] [Abstract][Full Text] [Related]
39. Updates on Paget's Disease of Bone.
Choi YJ; Sohn YB; Chung YS
Endocrinol Metab (Seoul); 2022 Oct; 37(5):732-743. PubMed ID: 36327984
[TBL] [Abstract][Full Text] [Related]
40. Paget's disease of bone: presentation, extent and response to bisphosphonates.
Wang LM; Au-Yeong ML; McKenna MJ
Ir Med J; 2002 Sep; 95(8):244, 246. PubMed ID: 12405502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
